Sign in

Samuel A. Myers' lab

@samyers-lab.bsky.social
343 followers 423 following 156 posts

Laboratory for Immunochemical Circuits at the La Jolla Institute for Immunology. Dept. of Pharmacology and Moore's Cancer Center, UCSD. Global Autoimmune Institute Assistant Professor. samyerslab.org

PostsRepliesMedia
Reposted by Samuel A. Myers' lab
bioRxivpreprint @biorxivpreprint.bsky.social · 01/10/2026
TET loss of function selects for aneuploidies that confer a proliferative advantage www.biorxiv.org/content/10.64898/20…
011
Samuel A. Myers' lab @samyers-lab.bsky.social · 25/09/2026
"Forty percent? I would mouth-pipette anything you put in front of me. Name the solvent. Name the concentration. I’ll do it. I’ll do it at the faculty meeting. I don’t care. Give these kids their money." inpreparation.substack.com/p/opinion-re...
011
Reposted by Samuel A. Myers' lab
Maitreya Dunham @maitreya.bsky.social · 24/09/2026
Exciting news: @uwgenome.bsky.social will be hiring for two tenure-track faculty positions this year, one open rank and one assistant professor. Both are “Genome Sciences” interpreted broadly so we welcome applicants working in a variety of fields and methods. Ad will be out shortly.
1104101
Samuel A. Myers' lab @samyers-lab.bsky.social · 23/09/2026
Wow. Major loss.
001
Reposted by Samuel A. Myers' lab
Prof. Shane Crotty @profshanecrotty.bsky.social · 21/09/2026
How durable is T cell memory in the human upper airway? Our new preprint directly tracks virus-specific CD8 & CD4 T cells in human nasal tissues for >18 months—using nearly 900 monthly nasal samples. www.biorxiv.org/content/10.6...
1135
Samuel A. Myers' lab @samyers-lab.bsky.social · 21/09/2026
One benefit of everyone using AI to review papers is that you get the same comments from three reviewers rather than three unique sets of comments....
051
Reposted by Samuel A. Myers' lab
Hiten Madhani @hitenmadhani.bsky.social · 17/09/2026
Reading and discussing (good) papers is one of the best ways to learn how to do good science. The struggle trains the mind. AI is not particularly good at judgement or critical thinking. Especially when the flaws are not obvious.
0104
Reposted by Samuel A. Myers' lab
La Jolla Institute for Immunology (LJI) @lji.org · 15/09/2026
We've kicked off the 2026 LEAD Day program! This afternoon features a panel with: 👉 Eric Topol, MD, Scripps Research VP @erictopol.bsky.social 👉 LJI Associate Prof. Ferhat Ay, Ph.D. @ferhatay.bsky.social 👉 Global Autoimmune Disease Assistant Prof. Sam Myers, Ph.D. @samyers-lab.bsky.social 1/🧵
Photo of a conference room with people looking at a speaker at a lecturn
132
Reposted by Samuel A. Myers' lab
La Jolla Institute for Immunology (LJI) @lji.org · 15/09/2026
Starting at 1:30pm Pacific today — We'll be live-posting from the LEAD Day scientific panel at Scripps Seaside Forum. ☀️ Stay tuned for #AutoimmuneDisease insights from LJI experts and Dr. Eric Topol (@erictopol.bsky.social)! Made possible by @autoimmunegai.bsky.social
Graphic with the La Jolla Institute logo and a banner for "LEAD Day: Lectures, Empowerment, and Awareness for Autoimmune Disease." Text reads: Scientific session designed for researchers. Event title "AI and Multi-Omics: Building a new era of autoimmune and chronic disease research," featuring Eric Topol, MD, Executive Vice President of Scripps Research, Ferhat Ay, Ph.D., La Jolla Institute for Immunology Associate Professor, Sam Myers, Ph.D., La Jolla Institute for Immunology, GLobal Autoimmune Institute Assistant Professor. Made possible by the generous support of Global Autoimmune Institute. tagline: "Empowering solutions."
032
Reposted by Samuel A. Myers' lab
Kermit Murray @kkmurray.bsky.social · 04/09/2026
(BioRxiv All) Background proteome correction promotes confident identification of dynamic protein-protein interactions between different biological contexts: Affinity purification-mass spectrometry (AP-MS) enables the characterization of protein-protein interactions (PPIs),… #BioRxiv #MassSpecRSS
dlvr.it
Background proteome correction promotes confident identification of dynamic protein-protein interactions between different biological contexts
Affinity purification-mass spectrometry (AP-MS) enables the characterization of protein-protein interactions (PPIs), and the ease and sensitivity of such experiments has progressively increased. Beyond steady-state interactions of target proteins, a strong interest has emerged in monitoring how PPIs change upon significant biological perturbations, such as in disease contexts or small molecule modulation of the target protein. These perturbations likely not only induce PPI changes but can also lead to altered expression of proteins not of direct interest. Changes in protein abundance may alter which proteins adsorb to the affinity purification matrix, and due to the sensitivity of modern mass spectrometers, these differential ''background binders'' can masquerade as differential interactors. Contemporary approaches often do not account for differences in the background proteome, potentially inflating the number of false positives and negatives reported. Here, we provide technical considerations for the reliable annotation of dynamic PPIs, using the O-GlcNAc transferase (OGT) as a case study. We describe the installation of affinity epitope tags on endogenous OGT in mouse embryonic stem cells (mESCs), which we then apply for OGT interactor identification via AP-MS. We show that accurate representation of the bead background, which depends on the affinity matrix in use, is critical for elimination of false positive and false negative PPIs. This became even more pertinent as OGT PPI dynamics were measured under OGT catalytic inhibition via OSMI-4, which is known to perturb gene expression. The proteomes of OSMI-4-treated and control-treated mESCs differed, leading to distinct bead backgrounds in which the differential background proteins appeared as interaction gains or losses. These false positives were resolved by incorporating straightforward experimental controls through a practical statistical framework, allowing for a direct and confident comparison between treatment conditions. Incorporating these considerations into workflows investigating PPI dynamics will improve data fidelity and reproducibility.
021
Samuel A. Myers' lab @samyers-lab.bsky.social · 11/09/2026
Favorite of mine
001
Samuel A. Myers' lab @samyers-lab.bsky.social · 11/09/2026
Kozak strikes again
000
Samuel A. Myers' lab @samyers-lab.bsky.social · 06/09/2026
bsky.app/profile/samy...
static.klipy.com
I See You Mac - Predator
ALT: I See You Mac - Predator
010
Samuel A. Myers' lab @samyers-lab.bsky.social · 06/09/2026
With the sensitivity of modern LC-MS, analyzing changes in protein complexes across differing biological systems will lead to false positives from the background proteomes. We provide some work arounds This also allowed us to identify interesting biology concerning OGT-protein complexes #glycotime
163
Reposted by Samuel A. Myers' lab
Matt Pratt @mattrpratt.bsky.social · 04/09/2026
@tommorelloofficial.bsky.social We are celebrating your former band mate and Nobel winner Carolyn Bertozzi’s 60th birthday in October. Over 300 people will be in attendance at Stanford. I am a former student of her’s, and a happy birthday message from you would be amazing to include.
043
Reposted by Samuel A. Myers' lab
bioRxivpreprint @biorxivpreprint.bsky.social · 03/09/2026
Background proteome correction promotes confident identification of dynamic protein-protein interactions between different biological contexts www.biorxiv.org/content/10.64898/20…
031
Reposted by Samuel A. Myers' lab
Kai Ryssdal @kairyssdal.bsky.social · 31/08/2026
Do this…
10520178
Reposted by Samuel A. Myers' lab
La Jolla Institute for Immunology (LJI) @lji.org · 31/08/2026
Experimental LJI cancer strategy wins top honors from Nucleate San Diego! Team leader Erik Ehinger, Ph.D., shares how new #cancer strategy could counteract T cell "exhaustion:" www.lji.org/news-events/... #immunology #ImmuneSystem #CancerResearch #SanDiego #LaJolla
lji.org
Experimental LJI cancer strategy wins top honors from Nucleate San Diego
Team leader Erik Ehinger, Ph.D., is on a mission to help more patients benefit from cancer immunotherapies.
021
Samuel A. Myers' lab @samyers-lab.bsky.social · 01/09/2026
OGT complexes....
static.klipy.com
Homer Simpson Drools with Anticipation
ALT: Homer Simpson Drools with Anticipation
021
Reposted by Samuel A. Myers' lab
U of Utah Dept of Biochemistry @uofubiochem.bsky.social · 31/08/2026
Don't miss Thursday's seminar by Dr. Greg Ducker @duckerlab.bsky.social entitled "Follow the Carbon: From Molecules to Mechanisms of Disease." Thurs Sept 3, 12pm in HSEB 1750!
253
Reposted by Samuel A. Myers' lab
Waggoner Lab @labwaggoner.bsky.social · 27/08/2026
A Zika virus vaccine with E protein fusion loop mutations protects via CD8+ T cells @natmicrobiol.nature.com www.nature.com/articles/s41... @lji.org
173
Reposted by Samuel A. Myers' lab
Edward Marcotte @edwardmarcotte.bsky.social · 25/08/2026
The window for public comments is still open but closes soon (tonight!) for NSF's proposed changes to require approval by political appointees, add restrictions to publishing & communication of research, and ban international collaborations.
111
Samuel A. Myers' lab @samyers-lab.bsky.social · 22/08/2026
Farewell Feli,best of luck on your last year in undergrad. Great to have you around this Summer. May your future be as bright as it was taking this photo. He's doing a maxi prep then driving home tonight. #dedicated.
020
Samuel A. Myers' lab @samyers-lab.bsky.social · 20/08/2026
The best part about being a PI is that I dont have to submit the manuscripts through the journal's portal anymore. I get to let the students and postdocs "experience" it. >:)
030
Reposted by Samuel A. Myers' lab
La Jolla Institute for Immunology (LJI) @lji.org · 18/08/2026
🗓️ Sept. 15, from 1:30-3:00 PM, @ Scripps Seaside Forum Join #SanDiego scientists for the LEAD Day scientific panel on "AI and Multi-Omics: Building a New Era of Autoimmune and Chronic Disease Research." #AI #Health #Medicine Free registration + complementary shuttle 👉 Sign up today: bit.ly/4g5hx7l
021
Reposted by Samuel A. Myers' lab
Ruth Huttenhain @rhuttenhain.bsky.social · 13/08/2026
My lab at Stanford University School of Medicine is recruiting! We are looking for a postdoc at the interface of quantitative proteomics, structural biology and G protein-coupled receptor (GPCR) biology: postdocs.stanford.edu/prospective/...
postdocs.stanford.edu
Open Postdoctoral position, faculty mentor Ruth Huttenhain | Office of Postdoctoral Affairs
03831
Reposted by Samuel A. Myers' lab
Geoff Faulkner @faulknerlab.bsky.social · 30/07/2026
Our study published today @science.org shows that X-chromosome inactivation (XCI) attracts L1 mutations to the human X chromosome: doi.org/10.1126/scie... With outstanding Perspective from @aurelien-doucet.bsky.social & @retrogenomics.bsky.social: doi.org/10.1126/scie...
58136
Samuel A. Myers' lab @samyers-lab.bsky.social · 23/07/2026
You can definitely tell @sandiegocomic-con.bsky.social is here. Welcome! And I'll see you Sunday.
000
Reposted by Samuel A. Myers' lab
Rebecca Berrens @rberrens.bsky.social · 10/07/2026
Hi #TEsky, please remember that we have an amazing community in the TransposonsWorldWide slack channel (join.slack.com/t/transposon...), which I encourage you to join. Another great resource is tehub.org. Please share !
join.slack.com
Join TransposonsWorldwide on Slack
Slack is a new way to communicate with your team. It’s faster, better organized, and more secure than email.
13622
Reposted by Samuel A. Myers' lab
Fabian Rivera-Chávez @fabianrchavez.bsky.social · 10/07/2026
1/ Excited to share a new preprint! My PhD student Claire asked why neonatal mice become resistant to experimental cholera as they age. Turns out, early-life acquisition of maternally transmitted lactobacilli helps protect against experimental cholera www.biorxiv.org/content/10.6...
biorxiv.org
Early-life acquisition of Lactobacillaceae protects against experimental cholera
Cholera causes severe diarrheal illness in young children, but the mechanisms underlying age-dependent susceptibility remain unclear. Experimental cholera in neonatal mice recapitulates age-dependent ...
1206
Samuel A. Myers' lab @samyers-lab.bsky.social · 10/07/2026
Oh yeah, dissect that overlapping transcriptional functionnnn
010
Reposted by Samuel A. Myers' lab
Nature @nature.com · 08/07/2026
Ryan Rising creates programmes that help people who have been incarcerated to access academic opportunities go.nature.com/3RmOzWU
go.nature.com
I want to see a prison-to-PhD pipeline
Ryan Rising creates programmes that help people who have been incarcerated to access academic opportunities.
14312
Reposted by Samuel A. Myers' lab
Lucas Sullivan @lucasbsullivan.bsky.social · 06/07/2026
Check out our recent Spotlight article in @cp-trendsendomet.bsky.social discussing intriguing new findings in mitochondrial lactate metabolism, written by graduate student Serwah Danquah! Paywall bypass link: authors.elsevier.com/a/1nNcv3jDgW...
256
Reposted by Samuel A. Myers' lab
Kermit Murray @kkmurray.bsky.social · 03/07/2026
(BioRxiv All) GLproxScape reconstructs spatial chromatin occupancy landscapes from tiled genomic locus proteomics: Genomic locus proteomics combines proximity labeling with mass spectrometry to identify the proteins associated with user-defined genomic loci. However,… #BioRxiv #MassSpecRSS
dlvr.it
GLproxScape reconstructs spatial chromatin occupancy landscapes from tiled genomic locus proteomics
Genomic locus proteomics combines proximity labeling with mass spectrometry to identify the proteins associated with user-defined genomic loci. However, per-region enrichment values from tiledguide designs are typically pooled before hit calling, collapsing the latent spatial structure encodedby overlapping measurements. Here, we describe GLproxScape, an R package that treats per-region enrichments as indirect spatial measurements and reconstructs latent chromatin occupancylandscapes through a Gaussian labeling-kernel forward model. Sequence-specific transcriptionfactors are resolved by motif-anchored non-negative least-squares deconvolution against JASPARor HOCOMOCO position weight matrices, while chromatin regulators which lack defined DNA-binding motifs are inferred as broad occupancy zones, enabling recovery of overlapping membersof multi-subunit complexes. Applied to published genomic locus proteomics datasets at the humanTERT, MYC, FOXP2, and FOXQ1 loci and the mouse Ripk3 locus, GLproxScape recovered knownregulators with predicted positions independently supported by ChIP-Atlas peaks, reconstructedcandidate co-binding relationships, and identified chromatin complexes inaccessible to pooledanalyses. Systematic sgRNA-ablation experiments further showed that densely tiled designsimprove event recovery and positional stability, providing concrete experimental guidance for futuregenomic locus proteomics studies.
022
Samuel A. Myers' lab @samyers-lab.bsky.social · 03/07/2026
www.samyerslab.org/lab-photos
000
Samuel A. Myers' lab @samyers-lab.bsky.social · 02/07/2026
Farewell Lisa, Pharmacy school at UCSF
020
Reposted by Samuel A. Myers' lab
Ruth Huttenhain @rhuttenhain.bsky.social · 30/06/2026
Preprint out! We optimized synchro-PASEF for phosphoproteomics & found equivalent biological insights to dia-PASEF despite fewer total IDs. Practical tip: apply retention time summation factor 2 to any PASEF phosphoproteomics data—you'll gain IDs and precision. www.biorxiv.org/content/10.6...
biorxiv.org
Systematic optimization and benchmarking of synchro-PASEF for high-throughput phosphoproteome profiling
High-throughput data-independent acquisition (DIA) workflows paired with short chromatographic separations are increasingly adopted for systems biology and clinical proteomics. However, narrower peak ...
293
Samuel A. Myers' lab @samyers-lab.bsky.social · 29/06/2026
I think my lab does this to me but I can't ever remember.
110
Reposted by Samuel A. Myers' lab
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 25/06/2026
Stacy Malaker @yalepress.bsky.social representing #glycotime and #massspec @onoinitiative.bsky.social chem bio symposium @stanford-chemh.bsky.social
0203
Samuel A. Myers' lab @samyers-lab.bsky.social · 27/06/2026
Second that
011
Samuel A. Myers' lab @samyers-lab.bsky.social · 23/06/2026
Going to be a great meeting!
000
Reposted by Samuel A. Myers' lab
Hattie Chung @hattaca.bsky.social · 19/06/2026
How does aging reshape a tissue that must continually rebuild itself hundreds of times? Our latest: Using spatial transcriptomics, we find that ovarian aging disrupts the coordination of cells across space and time before reproductive cycles stop. #OvarianAging
094
Reposted by Samuel A. Myers' lab
Fabian Rivera-Chávez @fabianrchavez.bsky.social · 09/06/2026
Now published in Cell Reports! @cellpress.bsky.social www.cell.com/cell-reports... My postdoc Dr. Maria de la Paz Gutierrez led this work showing that cholera toxin drives epithelial L-lactate production in the small intestine, creating a nutrient that Vibrio cholerae exploits during disease
cell.com
Cholera-toxin-induced disease generates epithelial-cell-derived L-lactate that promotes Vibrio cholerae growth in the small intestine
Gutierrez et al. show that cholera toxin induces epithelial LDHA-dependent L-lactate production in the small intestine, creating a nutrient niche that Vibrio cholerae exploits through LldD-mediated L-...
03812
Reposted by Samuel A. Myers' lab
Samuel A. Myers' lab @samyers-lab.bsky.social · 09/06/2026
Come discuss advances in research and patient care regarding O-GlcNAc transferase, OGT, and it's mutations that lead it neurodevelopmental disorders mbg.au.dk/ogtid #glycotime
001
Samuel A. Myers' lab @samyers-lab.bsky.social · 09/06/2026
Come discuss advances in research and patient care regarding O-GlcNAc transferase, OGT, and it's mutations that lead it neurodevelopmental disorders mbg.au.dk/ogtid #glycotime
001
Reposted by Samuel A. Myers' lab
Susan Klaeger @susanklaeger.bsky.social · 02/06/2026
Excited to introduce MIRA-MS, a real time artificial intelligence prediction tool for analysis of MHC peptides! If you are at ASMS, check out poster 459 on Thursday. www.biorxiv.org/content/10.6...
biorxiv.org
1154
Samuel A. Myers' lab @samyers-lab.bsky.social · 01/06/2026
Welcome to San Diego for #ASMS2026. The talks may knock your socks off. This guy's ready.
260
Samuel A. Myers' lab @samyers-lab.bsky.social · 30/05/2026
SAM Diegooooo
110
Reposted by Samuel A. Myers' lab
Kermit Murray @kkmurray.bsky.social · 17/05/2026
(BioRxiv All) PrEditR: A protein-centric platform for CRISPR-mediated base editor sgRNA design: Post-translational modifications (PTMs) are critical to protein function, yet the function of most known modification sites remains uncharacterized. CRISPR-mediated phenotypic… #BioRxiv #MassSpecRSS
dlvr.it
PrEditR: A protein-centric platform for CRISPR-mediated base editor sgRNA design
Post-translational modifications (PTMs) are critical to protein function, yet the function of most known modification sites remains uncharacterized. CRISPR-mediated phenotypic screens using base editors offer a powerful approach to dissecting PTM function at scale. However, existing sgRNA design tools for base editing applications are DNA-centric and lack the throughput required to integrate seamlessly with mass-spectrometry-based proteomics experimental outputs. We introduce protein editing in R, PrEditR, an open-source, protein-centric tool for high-throughput sgRNA design for custom base editor screens. PrEditR enables users to designate specific amino acid residues in proteins and design protospacer sequences to target the endogenous gene to install missense mutations via base editors.
021
Samuel A. Myers' lab @samyers-lab.bsky.social · 17/05/2026
PrEditR takes mass spectrometry–based phosphoproteomic data outputs (and other PTMs) and designs sgRNA sequences to introduce site-specific amino acid substitutions in endogenous genes for functional evaluation using CRISPR-mediated base editing. Try it and let us know what you think.
191